Skip to main navigation Skip to search Skip to main content

Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES)

Activity: Talk or presentationOral presentationResearch

Period29 May 2020
Event titleASCO annual meeting
Event typeConference